Characterization of aerosol output from various nebulizer/compressor combinations

Annals of Allergy, Asthma and Immunology

Volumn 86, Issue 5, 2001, Pages 566-574

  Reisner, Colin ^a   Katial, Rohit K ^b   Bartelson, B Bucher ^b   Buchmeir, Andrea ^b   Rosenwasser, Lanny J ^b   Nelson, Harold S ^b  

^a GLAXOSMITHKLINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

AEROSOL; ARTICLE; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLOW RATE; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0035013187     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62906-7     Document Type: Article

References (44)

1. Nelson HS, Spector SL, Whitsett TL, et al. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. J Allergy Clin Immunol 1983;72:371-375.
2. Blake KV, Hoppe M, Harman E, Hendeles L. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution: bioassay by histamine bronchoprovocation. Chest 1992;101: 309-315.
3. Bowton DL. Metered-dose inhalers versus hand-held nebulizers. Some answers and new questions. Chest 1992; 101:298-299.
4. Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. Chest 1992;101:305-308.
5. Tenholder MF, Bryson MJ, Whitlock WL. A model for conversion from small volume nebulizer to metered dose inhaler aerosol therapy. Chest 1992;101:634-637.
6. Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest 1993;104:1332-1337.
7. Kisch GL, Paloucek FP. Metered-dose inhalers and nebulizers in the acute setting. Ann Pharmacother 1992;26:92-95.
8. Turner MO, Patel A, Ginsburg S, FitzGerald JM. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med 1997; 157:1736-1744.
9. Williams JR, Bothner JP, Swanton RD. Delivery of albuterol in a pediatric emergency department. Pediatr Emerg Care 1996;12:263-267.
10. Newhouse MT. Emergency department management of life-threatening asthma. Are nebulizers obsolete? Chest 1993;103:661-663.
11. Premarket Notification 510(k); Regulatory Requirements for Medical Devices. U.S. Department of Health and human Services. FDA 1995:95-4158.
12. PDR Physicians' Desk Reference, 52nd edition. Montvale NJ: Medical Economics, 1998.
13. O'Callaghan C, Clark AR, Milner AD. Why nebulise for more than five minutes? Arch Dis Child 1989;64: 1270-1273.
14. Malone RA, Hollie MC, Glynn-Barnhart A, Nelson HS. Optimal duration of nebulized albuterol therapy. Chest 1993;104:1114-1118.
15. Smith JE, Jordan ML. Mathematical and graphical interpretation of the lognormal law for particle size distribution analysis. J Colloid Sci 1964;19: 549-559.
16. Pierson DJ. Toward international consensus on clinical aerosol administration. Chest 1991;100:1100-1101.
17. Dolovich MA. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir Care 2000;45:597-608.
18. Dolovich MA, MacIntyre NR, Anderson PJ, et al. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. Respir Care 2000;45:589-596.
19. Hess DR. Nebulizers: principles and performance. Respir Care 2000;45: 609-622.
20. Karpel JP, Schacter EN, Fanta C, et al. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest 1996;110: 611-616.
21. Clay MM, Pavia D, Newman SP, Clarke SW. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983;38:755-759.
22. Hess D, Horney D, Snyder T. Medication-delivery performance of eight small-volume, hand-held nebulizers: effects of diluent volume, gas flowrate, and nebulizer model. Respir Care 1989;34:717-723.
23. Kradjan WA, Lakshminarayan S. Efficiency of air compressor driven nebulizers. Chest 1985;87:512-516.
24. Langford SA, Allen MD. Salbutamol output from two jet nebulizers. Respir Med 1993;87:99-103.
25. Hardy JG, Newman SP, Knoch M. Lung deposition from four nebulizers. Respir Med 1993;87:461-465.
26. Newman SP, Pellow PG, Clay MM, Clarke SW. Evaluation of jet nebulisers for use with gentamicin solution. Thorax 1985;40:671-676.
27. Ferron GA, Kerrebijn KF, Weber J. Properties of aerosols produced with three nebulizers. Am Rev Respir Dis 1976;114:899-908.
28. O'Doherty MJ, Thomas S, Page C, et al. Differences in relative efficiency of nebulisers for pentamidine administration. Lancet 1988;2:1283-1286.
29. Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers. How reliable are they? Chest 1992;101:316-319.
30. Hollie MC, Malone RA, Skufca RM, Nelson HS. Extreme variability in aerosol output of the DeVilbiss 646 jet nebulizer. Chest 1991;100:1339-1344.
31. Loffert DT, Ikle D, Nelson HS. A comparison of commercial jet nebulizers. Chest 1994;106:1788-1792.
32. Hess D, Fisher D, Williams P, et al. Medication nebulizer performance: effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996; 110:498-505.
33. Barry PW, O'Callaghan C. An in vitro analysis of the output of salbutamol from different nebulizers, Eur Respir J 1999;13:1164-1169.
34. Etzler FM, Sanderson ML. Particle size analysis: a comparative study of various methods. Part Part Syst Charact 1995;12:217-224.
35. Saari SM, Vidgren MT, Koskinen MO, et al. Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. Chest 1998; 113:1573-79.
36. Weiner P, Berar-Yanay N, Davidovich A, Magadle R. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate. Chest 1999;116:931-934.
37. Lourenco RV, Klimek MF, Borowski CJ. Deposition and clearance of 2 μ particles in the tracheobronchial tree of normal subject-smokers and non-smokers. J Clin Invest 1971;50: 1411-1420.
38. Camner P, Mossberg B, Philipson K, Strandberg K. Elimination of test particles from the human tracheobronchial tract by voluntary coughing. Scand J Respir Dis 1979;60:56-62.
39. Bohning DE, Albert RE, Lippmann M, Foster WM. Tracheobronchial particle deposition and clearance. A study of the effects of cigarette smoking in monozygotic twins. Arch Environ Health 1975;30:457-462.
40. Vastag E, Matthys H, Kohler D, et al. Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subjects who never smoked. Eur J Respir Dis Suppl 1985;139:93-100.
41. Ericsson CH, Svartengren K, Svartengren M, et al. Repeatability of airway deposition and tracheobronchial clearance rate over three days in chronic bronchitis. Eur Respir J 1995;8: 1886-1893.
42. Douglas JG, Leslie MJ, Crompton GK, Grant IW. A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma. Br J Dis Chest 1986; 80:55-58.
43. Hadfield JW, Windebank WJ, Bateman JR. Is driving gas flow rate clinically important for nebulizer therapy? Br J Dis Chest 1986;80:50-54.
44. Douglas JG, Leslie MJ, Crompton GK, Grant IW. Is the flow rate used to drive a jet nebuliser clinically important? Br Med J (Clin Res Ed) 1985;290:29.